1. DFID announces £25 million for deworming and schistosomiasis treatments, and cites the impact on school enrolment as a key justification.

2. GlaxoSmithKline announce a donation of 400 million deworming pills a year for 5 years for kids in Africa.

3. Michael Clemens (CGD) and Gabriel Demombynes (World Bank) look at the Millennium Villages in Kenya, and how they are not being evaluated.

4. A new randomized evaluation of management consultants for Indian factories finds huge effects.

5. USAID launches a new Development Innovation Ventures fund, dedicated to funding new experiments, and scaling-up what works (sound familiar?).